MiMedx Group (MDXG) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SI-BONE (SIBN) has outperformed MiMedx Group (MDXG) over the past year, gaining 24.0% versus a loss of 34.9%. Over five years, SIBN leads with a -17.5% price change compared with -31.7% for MDXG. SI-BONE is the larger company by market cap ($862.5 million vs $683.7 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MDXG | SIBN |
|---|---|---|
| Share price | $4.69 | $19.25 |
| Market cap | $683.70M | $862.53M |
| 1-day change | +1.41% | +2.04% |
| YTD return | -31.76% | -4.36% |
| 1-year return | -34.93% | +24.00% |
| 5-year return | -31.66% | -17.46% |
| P/E ratio (TTM) | 117.13 | — |
| Forward P/E | 23.43 | — |
| EPS (TTM) | $0.04 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.97 | $21.89 |
| 52-week low | $3.03 | $11.48 |
| Distance from 52-week high | -41.22% | -12.08% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +57.95% | +31.05% |
| Average volume | 1.23M | 543.48K |
| Shares outstanding | 145.93M | 44.82M |
| Employees | 808 | 376 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed MDXG by 58.9 percentage points over the past year.
About MiMedx Group
MDXG stock →MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare.
Health Care · Medical/Dental Instruments · 808 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
MDXG vs SIBN FAQ
Which is bigger, MiMedx Group or SI-BONE?
SI-BONE (SIBN) is larger, with a market capitalization of $862.53M compared with $683.70M for MiMedx Group (MDXG).
Which stock has performed better over the past year, MDXG or SIBN?
SIBN returned +24.00% over the past 12 months, compared with -34.93% for MDXG (price return, excluding dividends). Past performance does not predict future results.
Are MiMedx Group and SI-BONE in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.